ATE382092T1 - Screeningverfahren für orthopoxvirus-antivirale mittel - Google Patents
Screeningverfahren für orthopoxvirus-antivirale mittelInfo
- Publication number
- ATE382092T1 ATE382092T1 AT03730996T AT03730996T ATE382092T1 AT E382092 T1 ATE382092 T1 AT E382092T1 AT 03730996 T AT03730996 T AT 03730996T AT 03730996 T AT03730996 T AT 03730996T AT E382092 T1 ATE382092 T1 AT E382092T1
- Authority
- AT
- Austria
- Prior art keywords
- orthopoxvirus
- screening methods
- antiviral agents
- poxvirus
- present
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/065—Poxviridae, e.g. avipoxvirus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Computational Biology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34564602P | 2002-01-08 | 2002-01-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE382092T1 true ATE382092T1 (de) | 2008-01-15 |
Family
ID=27804977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03730996T ATE382092T1 (de) | 2002-01-08 | 2003-01-08 | Screeningverfahren für orthopoxvirus-antivirale mittel |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7067248B2 (de) |
| EP (1) | EP1478770B1 (de) |
| JP (1) | JP2005531295A (de) |
| AT (1) | ATE382092T1 (de) |
| AU (1) | AU2003241267A1 (de) |
| CA (1) | CA2472119A1 (de) |
| DE (1) | DE60318299T2 (de) |
| DK (1) | DK1478770T3 (de) |
| ES (1) | ES2298523T3 (de) |
| PT (1) | PT1478770E (de) |
| WO (1) | WO2003075833A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005069012A2 (en) * | 2003-12-12 | 2005-07-28 | Transtech Pharma, Inc. | Ligands for i7l as modulators of orthopox viruses and methods for discovery thereof |
| EP1845155A4 (de) * | 2005-01-13 | 2008-11-05 | Kyushu Inst Technology | Partikel zum nachweis enzymatischer aktivität sowie verfahren und gerät zum nachweis enzymatischer aktivität unter verwendung davon |
| TW200907058A (en) | 2007-05-30 | 2009-02-16 | Wyeth Corp | Raccoon poxvirus expressing rabies glycoproteins |
| DE102009024720B4 (de) * | 2009-06-12 | 2022-02-24 | Bruker Daltonics GmbH & Co. KG | Massenspektrometrischer Endopeptidasen-Assay |
| MX2018008906A (es) * | 2016-01-21 | 2019-01-10 | Selux Diagnostics Inc | Metodos para pruebas rapidas de susceptibilidad antimicrobiana. |
| US10738338B2 (en) | 2016-10-18 | 2020-08-11 | The Research Foundation for the State University | Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate |
-
2003
- 2003-01-08 CA CA002472119A patent/CA2472119A1/en not_active Abandoned
- 2003-01-08 DK DK03730996T patent/DK1478770T3/da active
- 2003-01-08 EP EP03730996A patent/EP1478770B1/de not_active Expired - Lifetime
- 2003-01-08 PT PT03730996T patent/PT1478770E/pt unknown
- 2003-01-08 ES ES03730996T patent/ES2298523T3/es not_active Expired - Lifetime
- 2003-01-08 JP JP2003574109A patent/JP2005531295A/ja active Pending
- 2003-01-08 DE DE60318299T patent/DE60318299T2/de not_active Expired - Fee Related
- 2003-01-08 AT AT03730996T patent/ATE382092T1/de not_active IP Right Cessation
- 2003-01-08 AU AU2003241267A patent/AU2003241267A1/en not_active Abandoned
- 2003-01-08 WO PCT/US2003/000347 patent/WO2003075833A2/en active IP Right Grant
- 2003-01-08 US US10/504,687 patent/US7067248B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1478770A2 (de) | 2004-11-24 |
| US7067248B2 (en) | 2006-06-27 |
| AU2003241267A1 (en) | 2003-09-22 |
| WO2003075833A2 (en) | 2003-09-18 |
| EP1478770B1 (de) | 2007-12-26 |
| WO2003075833A3 (en) | 2004-05-27 |
| DK1478770T3 (da) | 2008-05-05 |
| CA2472119A1 (en) | 2003-09-18 |
| US20050233396A1 (en) | 2005-10-20 |
| DE60318299D1 (de) | 2008-02-07 |
| DE60318299T2 (de) | 2008-12-11 |
| PT1478770E (pt) | 2008-02-25 |
| JP2005531295A (ja) | 2005-10-20 |
| ES2298523T3 (es) | 2008-05-16 |
| EP1478770A4 (de) | 2005-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602006014694D1 (de) | Acyloxyalkylcarbamat-prodrugs von tranexansäure und anwendung | |
| MXPA04011612A (es) | Uso oftalmologico de roflumilasto para el tratamiento de enfermedades del ojo. | |
| DK1790354T3 (da) | Anvendelse af plasminogen til sårheling | |
| CY1112932T1 (el) | Αναστολεις sμαd7 για τη θεραπευτικη αγωγη ασθενειων του κνς | |
| UY30779A1 (es) | Derivados de dihidropiridina de utilidad como inhibidores de la proteina quinasa | |
| DK1307227T3 (da) | Farmaceutiske sammensætninger | |
| CY1107054T1 (el) | Ενωσεις διτοσυλικου αλατος κιναζολινης | |
| NO20055448L (no) | Kombinasjon av et analeptisk modafinil og en antidepressiv forbindelse for behandling av depresjon | |
| UY27455A1 (es) | Derivados n-(1,4,5,6-tetrahidro-ciclopentapirazol -3-il)- sustituidos. su obtención y uso como fármacos. | |
| ECSP045029A (es) | Composiciones de valdecoxib de disgregación intraoral | |
| NO20082986L (no) | Nye, acylisk substituerte furopyrimidinderivater og anvendelse derav for behandling av kardiovaskulaere lidelser | |
| DE60231107D1 (de) | Tetrahydro-pyrazinoä1,2-aüindole für die behandlung von krankheiten des zentralnervensystems | |
| CY1110369T1 (el) | Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη | |
| ATE492266T1 (de) | Farbverändernde mittel mit moringa extrakt | |
| CY1109666T1 (el) | Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας | |
| ATE382092T1 (de) | Screeningverfahren für orthopoxvirus-antivirale mittel | |
| Huerter et al. | A case of human orf contracted from a deer | |
| BR0312522A (pt) | Método para a preparação de trombina inativada por vìrus, trombina, formulação farmacêutica, e, kit farmacêutico | |
| BR0210650A (pt) | Tablete, e, uso do mesmo | |
| ATE433459T1 (de) | Desoxo-nonadepsipeptide | |
| NO20044530L (no) | Fremgangsmate for behandling av kognitive forstyrrelser | |
| CR7198A (es) | Tableta que contiene cetirizina y pseudoefedrina | |
| NO20061425L (no) | Kombinasjonen av en serotonin-reopptaksinbibitor og loxapin | |
| CY1110368T1 (el) | Συνεργιστικος συνδυασμος ο οποιος περιλαμβανει ροφλουμιλαστη και (r,r)-φορμοτερολη | |
| EA200501802A1 (ru) | Сочетание аналептина модафинила и антидепрессанта для лечения депресии |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1478770 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |